nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—NR3C1—Fluoxymesterone—breast cancer	0.329	1	CbGbCtD
Difluprednate—Megestrol acetate—Fluoxymesterone—breast cancer	0.061	0.108	CrCrCtD
Difluprednate—Fluprednidene Acetate—Exemestane—breast cancer	0.0553	0.0976	CrCrCtD
Difluprednate—Methylprednisolone—Exemestane—breast cancer	0.0517	0.0912	CrCrCtD
Difluprednate—Cortisone acetate—Fluoxymesterone—breast cancer	0.0475	0.0839	CrCrCtD
Difluprednate—Amcinonide—Fluoxymesterone—breast cancer	0.0424	0.0748	CrCrCtD
Difluprednate—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0413	0.0728	CrCrCtD
Difluprednate—Desoximetasone—Fluoxymesterone—breast cancer	0.0393	0.0693	CrCrCtD
Difluprednate—Fluorometholone—Fluoxymesterone—breast cancer	0.0383	0.0677	CrCrCtD
Difluprednate—Triamcinolone—Fluoxymesterone—breast cancer	0.0383	0.0677	CrCrCtD
Difluprednate—Mometasone—Fluoxymesterone—breast cancer	0.0383	0.0677	CrCrCtD
Difluprednate—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0383	0.0677	CrCrCtD
Difluprednate—Betamethasone—Fluoxymesterone—breast cancer	0.0374	0.0661	CrCrCtD
Difluprednate—Dexamethasone—Fluoxymesterone—breast cancer	0.0374	0.0661	CrCrCtD
Difluprednate—Macular oedema—Tamoxifen—breast cancer	0.0023	0.0644	CcSEcCtD
Difluprednate—Nerve injury—Paclitaxel—breast cancer	0.00148	0.0414	CcSEcCtD
Difluprednate—Macular oedema—Paclitaxel—breast cancer	0.00132	0.0371	CcSEcCtD
Difluprednate—Scab—Fluorouracil—breast cancer	0.00119	0.0334	CcSEcCtD
Difluprednate—Punctate keratitis—Capecitabine—breast cancer	0.00105	0.0294	CcSEcCtD
Difluprednate—Dry eye—Toremifene—breast cancer	0.000967	0.0271	CcSEcCtD
Difluprednate—Eye irritation—Letrozole—breast cancer	0.000959	0.0269	CcSEcCtD
Difluprednate—Lacrimation increased—Ixabepilone—breast cancer	0.000944	0.0265	CcSEcCtD
Difluprednate—Visual acuity reduced—Tamoxifen—breast cancer	0.000942	0.0264	CcSEcCtD
Difluprednate—Scab—Capecitabine—breast cancer	0.000832	0.0233	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AFP—breast cancer	0.000654	0.0101	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—RXRB—breast cancer	0.000642	0.00993	CbGpPWpGaD
Difluprednate—Blepharitis—Fluorouracil—breast cancer	0.000616	0.0173	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—RARB—breast cancer	0.000606	0.00937	CbGpPWpGaD
Difluprednate—Weight increased—Toremifene—breast cancer	0.000598	0.0168	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—KRT5—breast cancer	0.000598	0.00924	CbGpPWpGaD
Difluprednate—Herpes simplex—Goserelin—breast cancer	0.000581	0.0163	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—KRT14—breast cancer	0.000556	0.00859	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—NR2F1—breast cancer	0.000546	0.00843	CbGpPWpGaD
Difluprednate—Visual acuity reduced—Paclitaxel—breast cancer	0.000542	0.0152	CcSEcCtD
Difluprednate—Photophobia—Vinblastine—breast cancer	0.000542	0.0152	CcSEcCtD
Difluprednate—Weight increased—Exemestane—breast cancer	0.000526	0.0148	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—EBF1—breast cancer	0.000507	0.00784	CbGpPWpGaD
Difluprednate—Dry eye—Goserelin—breast cancer	0.000494	0.0139	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—breast cancer	0.00049	0.00758	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—PGR—breast cancer	0.000482	0.00744	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—breast cancer	0.00048	0.00743	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—RARB—breast cancer	0.000479	0.0074	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—breast cancer	0.000474	0.00732	CbGpPWpGaD
Difluprednate—Weight increased—Letrozole—breast cancer	0.000468	0.0131	CcSEcCtD
Difluprednate—Weight increased—Anastrozole—breast cancer	0.000468	0.0131	CcSEcCtD
Difluprednate—Visual acuity reduced—Capecitabine—breast cancer	0.000445	0.0125	CcSEcCtD
Difluprednate—Weight increased—Raloxifene—breast cancer	0.000444	0.0125	CcSEcCtD
Difluprednate—Eye irritation—Fluorouracil—breast cancer	0.000443	0.0124	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—DLX2—breast cancer	0.000438	0.00678	CbGpPWpGaD
Difluprednate—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000438	0.113	CrCbGaD
Difluprednate—Vision blurred—Toremifene—breast cancer	0.000432	0.0121	CcSEcCtD
Difluprednate—Photophobia—Thiotepa—breast cancer	0.00043	0.0121	CcSEcCtD
Difluprednate—Lacrimation increased—Irinotecan—breast cancer	0.000429	0.012	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—breast cancer	0.000428	0.00662	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—PABPC1—breast cancer	0.000426	0.00658	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR2—breast cancer	0.000424	0.00655	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—LEP—breast cancer	0.000417	0.00645	CbGpPWpGaD
Difluprednate—Lacrimation increased—Fluorouracil—breast cancer	0.000411	0.0115	CcSEcCtD
Difluprednate—Herpes simplex—Fluorouracil—breast cancer	0.000411	0.0115	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—CPT1A—breast cancer	0.000402	0.00621	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—breast cancer	0.000402	0.00621	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—breast cancer	0.000399	0.00617	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—breast cancer	0.000398	0.00615	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TWIST1—breast cancer	0.000384	0.00594	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PGR—breast cancer	0.000381	0.00588	CbGpPWpGaD
Difluprednate—Eye irritation—Paclitaxel—breast cancer	0.000378	0.0106	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—AR—breast cancer	0.000374	0.00579	CbGpPWpGaD
Difluprednate—Headache—Fluoxymesterone—breast cancer	0.000363	0.0102	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—DKK1—breast cancer	0.000362	0.00559	CbGpPWpGaD
Difluprednate—Photophobia—Fluorouracil—breast cancer	0.000356	0.00997	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—NCOA2—breast cancer	0.000355	0.00549	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—WNT10B—breast cancer	0.000352	0.00543	CbGpPWpGaD
Difluprednate—Herpes simplex—Paclitaxel—breast cancer	0.00035	0.00982	CcSEcCtD
Difluprednate—Lacrimation increased—Paclitaxel—breast cancer	0.00035	0.00982	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—NCOA2—breast cancer	0.000345	0.00533	CbGpPWpGaD
Difluprednate—Megestrol acetate—PGR—breast cancer	0.000343	0.0888	CrCbGaD
Difluprednate—Vision blurred—Letrozole—breast cancer	0.000337	0.00947	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—VDR—breast cancer	0.000336	0.0052	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR2—breast cancer	0.000335	0.00518	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—breast cancer	0.000334	0.00517	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—NRIP1—breast cancer	0.000327	0.00505	CbGpPWpGaD
Difluprednate—Eye irritation—Docetaxel—breast cancer	0.00032	0.00898	CcSEcCtD
Difluprednate—Weight increased—Tamoxifen—breast cancer	0.00032	0.00898	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—PTHLH—breast cancer	0.000315	0.00487	CbGpPWpGaD
Difluprednate—Eye irritation—Capecitabine—breast cancer	0.00031	0.00869	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—breast cancer	0.000308	0.00476	CbGpPWpGaD
Difluprednate—Weight increased—Goserelin—breast cancer	0.000306	0.00857	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—EGR1—breast cancer	0.000304	0.0047	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—MIF—breast cancer	0.000302	0.00466	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PRLR—breast cancer	0.000302	0.00466	CbGpPWpGaD
Difluprednate—Fluticasone Propionate—PLA2G4A—breast cancer	0.000299	0.0775	CrCbGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—NCOA1—breast cancer	0.000299	0.00463	CbGpPWpGaD
Difluprednate—Dry eye—Paclitaxel—breast cancer	0.000298	0.00836	CcSEcCtD
Difluprednate—Lacrimation increased—Docetaxel—breast cancer	0.000297	0.00832	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—YBX1—breast cancer	0.000296	0.00458	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HADHB—breast cancer	0.000296	0.00458	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—AR—breast cancer	0.000296	0.00457	CbGpPWpGaD
Difluprednate—Pruritus—Lapatinib—breast cancer	0.000291	0.00817	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—NCOA1—breast cancer	0.000291	0.00449	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ZNF432—breast cancer	0.000287	0.00444	CbGpPWpGaD
Difluprednate—Lacrimation increased—Capecitabine—breast cancer	0.000287	0.00806	CcSEcCtD
Difluprednate—Herpes simplex—Capecitabine—breast cancer	0.000287	0.00806	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—EZH2—breast cancer	0.000287	0.00444	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—AR—breast cancer	0.000287	0.00444	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—breast cancer	0.000286	0.00443	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—THRB—breast cancer	0.000283	0.00437	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—DDIT3—breast cancer	0.000282	0.00436	CbGpPWpGaD
Difluprednate—Pruritus—Fulvestrant—breast cancer	0.000268	0.00751	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—VDR—breast cancer	0.000266	0.00411	CbGpPWpGaD
Difluprednate—Pruritus—Toremifene—breast cancer	0.000264	0.00742	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SIRT1—breast cancer	0.000262	0.00404	CbGpPWpGaD
Difluprednate—Weight increased—Thiotepa—breast cancer	0.000261	0.00733	CcSEcCtD
Difluprednate—Eye pain—Paclitaxel—breast cancer	0.000259	0.00727	CcSEcCtD
Difluprednate—Headache—Lapatinib—breast cancer	0.000258	0.00724	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—breast cancer	0.000258	0.00398	CbGpPWpGaD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—breast cancer	0.000257	0.00397	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR1—breast cancer	0.000257	0.00397	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TCF7L2—breast cancer	0.000255	0.00395	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—GATA3—breast cancer	0.000255	0.00394	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—breast cancer	0.000253	0.00391	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—breast cancer	0.000251	0.00387	CbGpPWpGaD
Difluprednate—Dry eye—Capecitabine—breast cancer	0.000244	0.00686	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.000244	0.00377	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—breast cancer	0.000244	0.00377	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—NCOR1—breast cancer	0.000244	0.00376	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—EGR1—breast cancer	0.000243	0.00376	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—breast cancer	0.000239	0.0037	CbGpPWpGaD
Difluprednate—Headache—Fulvestrant—breast cancer	0.000237	0.00665	CcSEcCtD
Difluprednate—Headache—Toremifene—breast cancer	0.000234	0.00657	CcSEcCtD
Difluprednate—Pruritus—Exemestane—breast cancer	0.000233	0.00653	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—breast cancer	0.000231	0.00358	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—AHR—breast cancer	0.000227	0.0035	CbGpPWpGaD
Difluprednate—Weight increased—Mitoxantrone—breast cancer	0.000226	0.00633	CcSEcCtD
Difluprednate—Vision blurred—Goserelin—breast cancer	0.000221	0.00619	CcSEcCtD
Difluprednate—Pruritus—Ixabepilone—breast cancer	0.00022	0.00616	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—breast cancer	0.000217	0.00335	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—breast cancer	0.000216	0.00334	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—EGR1—breast cancer	0.000214	0.00331	CbGpPWpGaD
Difluprednate—Herpes simplex—Methotrexate—breast cancer	0.000214	0.006	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—breast cancer	0.000213	0.0033	CbGpPWpGaD
Difluprednate—Eye pain—Capecitabine—breast cancer	0.000213	0.00597	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—SMAD4—breast cancer	0.000212	0.00327	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—PRL—breast cancer	0.000211	0.00326	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—breast cancer	0.000211	0.00326	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—WNT1—breast cancer	0.000208	0.00321	CbGpPWpGaD
Difluprednate—Pruritus—Letrozole—breast cancer	0.000207	0.0058	CcSEcCtD
Difluprednate—Pruritus—Anastrozole—breast cancer	0.000207	0.0058	CcSEcCtD
Difluprednate—Headache—Exemestane—breast cancer	0.000206	0.00578	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.000205	0.00317	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—HIF1A—breast cancer	0.000205	0.00317	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—breast cancer	0.000204	0.00316	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR1—breast cancer	0.000203	0.00314	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—BMP4—breast cancer	0.000202	0.00312	CbGpPWpGaD
Difluprednate—Herpes simplex—Epirubicin—breast cancer	0.0002	0.00561	CcSEcCtD
Difluprednate—Lacrimation increased—Epirubicin—breast cancer	0.0002	0.00561	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—NR2F1—breast cancer	0.000199	0.00308	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CSF2—breast cancer	0.000199	0.00307	CbGpPWpGaD
Difluprednate—Fluticasone Propionate—PGR—breast cancer	0.000198	0.0513	CrCbGaD
Difluprednate—Headache—Ixabepilone—breast cancer	0.000194	0.00545	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—breast cancer	0.000193	0.00298	CbGpPWpGaD
Difluprednate—Vision blurred—Thiotepa—breast cancer	0.000189	0.00529	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—breast cancer	0.000188	0.00291	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—BMP2—breast cancer	0.000188	0.0029	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—breast cancer	0.000188	0.0029	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NR2F6—breast cancer	0.000185	0.00286	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—HNF4G—breast cancer	0.000185	0.00286	CbGpPWpGaD
Difluprednate—Lacrimation increased—Doxorubicin—breast cancer	0.000185	0.00519	CcSEcCtD
Difluprednate—Herpes simplex—Doxorubicin—breast cancer	0.000185	0.00519	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.000185	0.00286	CbGpPWpGaD
Difluprednate—Weight increased—Paclitaxel—breast cancer	0.000184	0.00517	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—breast cancer	0.000184	0.00284	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—breast cancer	0.000184	0.00284	CbGpPWpGaD
Difluprednate—Headache—Anastrozole—breast cancer	0.000183	0.00514	CcSEcCtD
Difluprednate—Headache—Letrozole—breast cancer	0.000183	0.00514	CcSEcCtD
Difluprednate—Betamethasone—PGR—breast cancer	0.000181	0.047	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—breast cancer	0.000179	0.00276	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—GATA3—breast cancer	0.000177	0.00273	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CSF2—breast cancer	0.000175	0.0027	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000175	0.0027	CbGpPWpGaD
Difluprednate—Headache—Raloxifene—breast cancer	0.000174	0.00487	CcSEcCtD
Difluprednate—Headache—Idarubicin—breast cancer	0.000174	0.00487	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—NCOA2—breast cancer	0.000173	0.00268	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—BAX—breast cancer	0.000172	0.00266	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP1—breast cancer	0.000171	0.00264	CbGpPWpGaD
Difluprednate—Dry eye—Epirubicin—breast cancer	0.00017	0.00478	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—HIF1A—breast cancer	0.000169	0.00262	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—PLAU—breast cancer	0.000168	0.00259	CbGpPWpGaD
Difluprednate—Vision blurred—Mitoxantrone—breast cancer	0.000163	0.00457	CcSEcCtD
Difluprednate—Pruritus—Chlorambucil—breast cancer	0.000159	0.00446	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—ESR1—breast cancer	0.000158	0.00244	CbGpPWpGaD
Difluprednate—Dry eye—Doxorubicin—breast cancer	0.000158	0.00442	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—SERPINE1—breast cancer	0.000157	0.00243	CbGpPWpGaD
Difluprednate—Weight increased—Docetaxel—breast cancer	0.000156	0.00438	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—NOTCH1—breast cancer	0.000156	0.00241	CbGpPWpGaD
Difluprednate—Vision blurred—Fluorouracil—breast cancer	0.000156	0.00438	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IL6—breast cancer	0.000156	0.00241	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—APC—breast cancer	0.000153	0.00236	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000153	0.00236	CbGpPWpGaD
Difluprednate—Triamcinolone—BCHE—breast cancer	0.000152	0.0393	CrCbGaD
Difluprednate—Weight increased—Capecitabine—breast cancer	0.000151	0.00424	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—breast cancer	0.00015	0.00232	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—breast cancer	0.000149	0.0023	CbGpPWpGaD
Difluprednate—Eye pain—Epirubicin—breast cancer	0.000148	0.00416	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MDM2—breast cancer	0.000147	0.00227	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—NCOA1—breast cancer	0.000146	0.00226	CbGpPWpGaD
Difluprednate—Clobetasol propionate—CYP1A1—breast cancer	0.000142	0.0368	CrCbGaD
Difluprednate—Dexamethasone—CYP17A1—breast cancer	0.000142	0.0368	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—FOS—breast cancer	0.000142	0.0022	CbGpPWpGaD
Difluprednate—Pruritus—Tamoxifen—breast cancer	0.000141	0.00397	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—breast cancer	0.000141	0.00218	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—breast cancer	0.00014	0.00217	CbGpPWpGaD
Difluprednate—Pruritus—Melphalan—breast cancer	0.000139	0.00389	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—ZNF432—breast cancer	0.000138	0.00214	CbGpPWpGaD
Difluprednate—Eye pain—Doxorubicin—breast cancer	0.000137	0.00385	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000137	0.00212	CbGpPWpGaD
Difluprednate—Pruritus—Goserelin—breast cancer	0.000135	0.00379	CcSEcCtD
Difluprednate—Vision blurred—Paclitaxel—breast cancer	0.000133	0.00373	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—ESRRA—breast cancer	0.000132	0.00204	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—STAT5A—breast cancer	0.00013	0.00201	CbGpPWpGaD
Difluprednate—Headache—Vinblastine—breast cancer	0.000129	0.00362	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000128	0.00198	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—JUN—breast cancer	0.000127	0.00197	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—breast cancer	0.000126	0.00195	CbGpPWpGaD
Difluprednate—Headache—Tamoxifen—breast cancer	0.000125	0.00351	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—FOS—breast cancer	0.000125	0.00194	CbGpPWpGaD
Difluprednate—Betamethasone—CYP19A1—breast cancer	0.000124	0.0322	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—NCOR1—breast cancer	0.000122	0.00189	CbGpPWpGaD
Difluprednate—Pruritus—Vinorelbine—breast cancer	0.000121	0.0034	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—AR—breast cancer	0.000121	0.00187	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MAPK8—breast cancer	0.000121	0.00186	CbGpPWpGaD
Difluprednate—Headache—Goserelin—breast cancer	0.00012	0.00336	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—THRB—breast cancer	0.000119	0.00184	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—E2F1—breast cancer	0.000118	0.00183	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IFNG—breast cancer	0.000118	0.00182	CbGpPWpGaD
Difluprednate—Dexamethasone—NOS2—breast cancer	0.000116	0.03	CrCbGaD
Difluprednate—Pruritus—Thiotepa—breast cancer	0.000116	0.00324	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—breast cancer	0.000115	0.00178	CbGpPWpGaD
Difluprednate—Cortisone acetate—CYP3A4—breast cancer	0.000115	0.0297	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—RXRB—breast cancer	0.000114	0.00177	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SRC—breast cancer	0.000114	0.00177	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CXCL8—breast cancer	0.00011	0.0017	CbGpPWpGaD
Difluprednate—Vision blurred—Capecitabine—breast cancer	0.000109	0.00306	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN1B—breast cancer	0.000107	0.00166	CbGpPWpGaD
Difluprednate—Headache—Vinorelbine—breast cancer	0.000107	0.00301	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HES1—breast cancer	0.000106	0.00164	CbGpPWpGaD
Difluprednate—Fluticasone furoate—CYP3A4—breast cancer	0.000106	0.0275	CrCbGaD
Difluprednate—Dexamethasone—PGR—breast cancer	0.000106	0.0273	CrCbGaD
Difluprednate—Weight increased—Epirubicin—breast cancer	0.000105	0.00295	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—IL2—breast cancer	0.000105	0.00162	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HNRNPR—breast cancer	0.000105	0.00162	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HNRNPK—breast cancer	0.000105	0.00162	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—breast cancer	0.000104	0.00161	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—CTNNB1—breast cancer	0.000104	0.0016	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—breast cancer	0.000103	0.0016	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—HIF1A—breast cancer	0.000103	0.00159	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—RELA—breast cancer	0.000103	0.00159	CbGpPWpGaD
Difluprednate—Headache—Thiotepa—breast cancer	0.000102	0.00287	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—CCND1—breast cancer	0.000102	0.00158	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—JUN—breast cancer	0.000102	0.00158	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CTNNB1—breast cancer	0.000101	0.00157	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LEP—breast cancer	0.000101	0.00156	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP9—breast cancer	9.93e-05	0.00153	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—PTEN—breast cancer	9.87e-05	0.00153	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP1B1—breast cancer	9.86e-05	0.0255	CrCbGaD
Difluprednate—Weight increased—Doxorubicin—breast cancer	9.74e-05	0.00273	CcSEcCtD
Difluprednate—Pruritus—Gemcitabine—breast cancer	9.72e-05	0.00273	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—breast cancer	9.67e-05	0.0015	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EEF1B2—breast cancer	9.59e-05	0.00148	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NR2F1—breast cancer	9.59e-05	0.00148	CbGpPWpGaD
Difluprednate—Pruritus—Fluorouracil—breast cancer	9.56e-05	0.00268	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL2—breast cancer	9.24e-05	0.00143	CbGpPWpGaD
Difluprednate—Megestrol acetate—ABCB1—breast cancer	9.2e-05	0.0238	CrCbGaD
Difluprednate—Flunisolide—CYP3A4—breast cancer	9.08e-05	0.0235	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—breast cancer	9.08e-05	0.0014	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	8.99e-05	0.00139	CbGpPWpGaD
Difluprednate—Paramethasone—CYP3A4—breast cancer	8.97e-05	0.0232	CrCbGaD
Difluprednate—NR3C1—Gene Expression—NR2F6—breast cancer	8.92e-05	0.00138	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HNF4G—breast cancer	8.92e-05	0.00138	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	8.91e-05	0.00138	CbGpPWpGaD
Difluprednate—Headache—Mitoxantrone—breast cancer	8.84e-05	0.00248	CcSEcCtD
Difluprednate—Headache—Irinotecan—breast cancer	8.84e-05	0.00248	CcSEcCtD
Difluprednate—Fluticasone furoate—ABCB1—breast cancer	8.84e-05	0.0229	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	8.8e-05	0.00136	CbGpPWpGaD
Difluprednate—Fluorometholone—CYP3A4—breast cancer	8.75e-05	0.0227	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	8.72e-05	0.00135	CbGpPWpGaD
Difluprednate—Headache—Gemcitabine—breast cancer	8.61e-05	0.00242	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	8.51e-05	0.00132	CbGpPWpGaD
Difluprednate—Headache—Fluorouracil—breast cancer	8.46e-05	0.00237	CcSEcCtD
Difluprednate—Methylprednisolone—CYP3A4—breast cancer	8.46e-05	0.0219	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—RB1—breast cancer	8.39e-05	0.0013	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	8.38e-05	0.00129	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IGF1—breast cancer	8.32e-05	0.00129	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—RARB—breast cancer	8.27e-05	0.00128	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	8.25e-05	0.00127	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MYC—breast cancer	8.2e-05	0.00127	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	8.18e-05	0.00126	CbGpPWpGaD
Difluprednate—Pruritus—Paclitaxel—breast cancer	8.14e-05	0.00228	CcSEcCtD
Difluprednate—Vision blurred—Methotrexate—breast cancer	8.12e-05	0.00228	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—HNRNPL—breast cancer	7.95e-05	0.00123	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—MED12—breast cancer	7.93e-05	0.00123	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SERPINE1—breast cancer	7.9e-05	0.00122	CbGpPWpGaD
Difluprednate—Vision blurred—Epirubicin—breast cancer	7.6e-05	0.00213	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	7.43e-05	0.00115	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	7.3e-05	0.00113	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP19A1—breast cancer	7.24e-05	0.0187	CrCbGaD
Difluprednate—Headache—Paclitaxel—breast cancer	7.21e-05	0.00202	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	7.19e-05	0.00111	CbGpPWpGaD
Difluprednate—Triamcinolone—CYP3A4—breast cancer	7.13e-05	0.0185	CrCbGaD
Difluprednate—Methylprednisolone—ABCB1—breast cancer	7.04e-05	0.0182	CrCbGaD
Difluprednate—Vision blurred—Doxorubicin—breast cancer	7.03e-05	0.00197	CcSEcCtD
Difluprednate—Triamcinolone—PTGS2—breast cancer	6.99e-05	0.0181	CrCbGaD
Difluprednate—Pruritus—Docetaxel—breast cancer	6.9e-05	0.00194	CcSEcCtD
Difluprednate—Dexamethasone—ABCG2—breast cancer	6.8e-05	0.0176	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TP53—breast cancer	6.74e-05	0.00104	CbGpPWpGaD
Difluprednate—Pruritus—Capecitabine—breast cancer	6.68e-05	0.00187	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—PGR—breast cancer	6.57e-05	0.00102	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EIF2S2—breast cancer	6.55e-05	0.00101	CbGpPWpGaD
Difluprednate—Fluticasone Propionate—CYP3A4—breast cancer	6.38e-05	0.0165	CrCbGaD
Difluprednate—NR3C1—Gene Expression—ESRRA—breast cancer	6.35e-05	0.000982	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	6.33e-05	0.000978	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CTNNB1—breast cancer	6.17e-05	0.000954	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL6—breast cancer	6.17e-05	0.000953	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	6.11e-05	0.000944	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	6.11e-05	0.000944	CbGpPWpGaD
Difluprednate—Headache—Docetaxel—breast cancer	6.11e-05	0.00171	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—CDKN1A—breast cancer	6.03e-05	0.000932	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—YBX1—breast cancer	6.02e-05	0.000931	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	5.94e-05	0.000917	CbGpPWpGaD
Difluprednate—Headache—Capecitabine—breast cancer	5.91e-05	0.00166	CcSEcCtD
Difluprednate—Betamethasone—CYP3A4—breast cancer	5.84e-05	0.0151	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	5.79e-05	0.000894	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	5.78e-05	0.000894	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—THRB—breast cancer	5.75e-05	0.000888	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EEF2—breast cancer	5.75e-05	0.000888	CbGpPWpGaD
Difluprednate—Betamethasone—PTGS2—breast cancer	5.72e-05	0.0148	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	5.55e-05	0.000857	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	5.53e-05	0.000855	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—TET2—breast cancer	5.51e-05	0.000852	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RXRB—breast cancer	5.51e-05	0.000852	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	5.48e-05	0.000847	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	5.43e-05	0.00084	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPL31—breast cancer	5.4e-05	0.000835	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—STAT3—breast cancer	5.38e-05	0.000832	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	5.38e-05	0.000831	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	5.33e-05	0.000825	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	5.33e-05	0.000824	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP1A1—breast cancer	5.33e-05	0.0138	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—AR—breast cancer	5.11e-05	0.00079	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	5.06e-05	0.000782	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPS4X—breast cancer	5.04e-05	0.000779	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	5.01e-05	0.000775	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TGFB1—breast cancer	4.99e-05	0.000771	CbGpPWpGaD
Difluprednate—Pruritus—Methotrexate—breast cancer	4.97e-05	0.0014	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—EIF3A—breast cancer	4.96e-05	0.000767	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—DNMT3A—breast cancer	4.89e-05	0.000755	CbGpPWpGaD
Difluprednate—Betamethasone—ABCB1—breast cancer	4.87e-05	0.0126	CrCbGaD
Difluprednate—NR3C1—Gene Expression—ELL—breast cancer	4.82e-05	0.000744	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	4.7e-05	0.000726	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TNF—breast cancer	4.66e-05	0.00072	CbGpPWpGaD
Difluprednate—Pruritus—Epirubicin—breast cancer	4.65e-05	0.00131	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	4.6e-05	0.000711	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—VDR—breast cancer	4.59e-05	0.00071	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	4.47e-05	0.000691	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PABPC1—breast cancer	4.46e-05	0.000689	CbGpPWpGaD
Difluprednate—Headache—Methotrexate—breast cancer	4.4e-05	0.00124	CcSEcCtD
Difluprednate—Pruritus—Doxorubicin—breast cancer	4.31e-05	0.00121	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—DNMT3B—breast cancer	4.18e-05	0.000645	CbGpPWpGaD
Difluprednate—Headache—Epirubicin—breast cancer	4.12e-05	0.00116	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—RPL23A—breast cancer	4.09e-05	0.000633	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	4.02e-05	0.000622	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HIST1H2BC—breast cancer	4.02e-05	0.000621	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HIST1H2BK—breast cancer	4.02e-05	0.000621	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RARB—breast cancer	3.98e-05	0.000616	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP2D6—breast cancer	3.96e-05	0.0103	CrCbGaD
Difluprednate—NR3C1—Gene Expression—MED12—breast cancer	3.82e-05	0.00059	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPS8—breast cancer	3.82e-05	0.00059	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPS7—breast cancer	3.82e-05	0.00059	CbGpPWpGaD
Difluprednate—Headache—Doxorubicin—breast cancer	3.81e-05	0.00107	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—IL6—breast cancer	3.76e-05	0.000581	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	3.51e-05	0.000542	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NOTCH4—breast cancer	3.46e-05	0.000535	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP3A4—breast cancer	3.4e-05	0.0088	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	3.39e-05	0.000524	CbGpPWpGaD
Difluprednate—Dexamethasone—PTGS2—breast cancer	3.33e-05	0.00862	CrCbGaD
Difluprednate—NR3C1—Gene Expression—HSPA1B—breast cancer	3.3e-05	0.00051	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	3.25e-05	0.000502	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PGR—breast cancer	3.16e-05	0.000489	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—DNMT1—breast cancer	3.1e-05	0.00048	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NCOA2—breast cancer	3.05e-05	0.000471	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EZH2—breast cancer	3.01e-05	0.000465	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NOTCH3—breast cancer	2.94e-05	0.000455	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PARP1—breast cancer	2.94e-05	0.000455	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	2.88e-05	0.000446	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPS6—breast cancer	2.87e-05	0.000444	CbGpPWpGaD
Difluprednate—Dexamethasone—ABCB1—breast cancer	2.83e-05	0.00733	CrCbGaD
Difluprednate—NR3C1—Gene Expression—ESR2—breast cancer	2.79e-05	0.000431	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NOTCH2—breast cancer	2.64e-05	0.000408	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NCOA1—breast cancer	2.57e-05	0.000397	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AR—breast cancer	2.46e-05	0.00038	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SIRT1—breast cancer	2.24e-05	0.000347	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SMAD4—breast cancer	2.22e-05	0.000342	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—VDR—breast cancer	2.21e-05	0.000342	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NCOR1—breast cancer	2.15e-05	0.000332	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—H2AFX—breast cancer	2.1e-05	0.000324	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ERCC2—breast cancer	2.02e-05	0.000313	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—MYC—breast cancer	1.83e-05	0.000282	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR1—breast cancer	1.69e-05	0.000261	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NOTCH1—breast cancer	1.63e-05	0.000252	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SERPINE1—breast cancer	1.39e-05	0.000215	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MAPK3—breast cancer	9.04e-06	0.00014	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MYC—breast cancer	8.79e-06	0.000136	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AKT1—breast cancer	6.09e-06	9.42e-05	CbGpPWpGaD
